LY56110 structure
|
Common Name | LY56110 | ||
---|---|---|---|---|
CAS Number | 26766-37-0 | Molecular Weight | 315.20 | |
Density | 1.296g/cm3 | Boiling Point | 438.3ºC at 760mmHg | |
Molecular Formula | C17H12Cl2N2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 251.5ºC |
Use of LY56110LY56110 is an orally active aromatase inhibitor. LY56110 inhibits P-450-dependent p-nitroanisole O-demethylation and ethylmorphine N-demethylation in hepatic microsomes isolated from rat, with the IC50 of 2.5 and 11 μΜ, respectively. LY56110 can be used for neurological disorder study[1][2]. |
Name | 5-[bis(4-chlorophenyl)methyl]pyrimidine |
---|---|
Synonym | More Synonyms |
Description | LY56110 is an orally active aromatase inhibitor. LY56110 inhibits P-450-dependent p-nitroanisole O-demethylation and ethylmorphine N-demethylation in hepatic microsomes isolated from rat, with the IC50 of 2.5 and 11 μΜ, respectively. LY56110 can be used for neurological disorder study[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.296g/cm3 |
---|---|
Boiling Point | 438.3ºC at 760mmHg |
Molecular Formula | C17H12Cl2N2 |
Molecular Weight | 315.20 |
Flash Point | 251.5ºC |
Exact Mass | 314.03800 |
PSA | 25.78000 |
LogP | 4.96360 |
Vapour Pressure | 1.79E-07mmHg at 25°C |
Index of Refraction | 1.625 |
~54% LY56110 CAS#:26766-37-0 |
Literature: Keenan, Martine; Abbott, Michael J.; Alexander, Paul W.; Armstrong, Tanya; Best, Wayne M.; Berven, Bradley; Botero, Adriana; Chaplin, Jason H.; Charman, Susan A.; Chatelain, Eric; Von Geldern, Thomas W.; Kerfoot, Maria; Khong, Andrea; Nguyen, Tien; McManus, Joshua D.; Morizzi, Julia; Ryan, Eileen; Scandale, Ivan; Thompson, R. Andrew; Wang, Sen Z.; White, Karen L. Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4189 - 4204 |
~26% LY56110 CAS#:26766-37-0 |
Literature: Taylor, Harold M.; Jones, C. David; Davenport, James D.; Hirsch, Kenneth S.; Kress, T.J.; Weaver, Dix Journal of Medicinal Chemistry, 1987 , vol. 30, # 8 p. 1359 - 1365 |
~% LY56110 CAS#:26766-37-0 |
Literature: Keenan, Martine; Abbott, Michael J.; Alexander, Paul W.; Armstrong, Tanya; Best, Wayne M.; Berven, Bradley; Botero, Adriana; Chaplin, Jason H.; Charman, Susan A.; Chatelain, Eric; Von Geldern, Thomas W.; Kerfoot, Maria; Khong, Andrea; Nguyen, Tien; McManus, Joshua D.; Morizzi, Julia; Ryan, Eileen; Scandale, Ivan; Thompson, R. Andrew; Wang, Sen Z.; White, Karen L. Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4189 - 4204 |
Precursor 2 | |
---|---|
DownStream 0 |
5-[(4-chlorophenyl)(4-chlorophenyl)methyl]pyrimidine |
5-(Bis(4-chlorophenyl)methyl)pyrimidine |